REFERENCE
- Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B,
Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J,
Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano
JL; ESC Scientific Document Group. 2017 ESC/EACTS guidelines for the
management of valvular heart disease. Eur Heart J.
2017;38(36):2739-2791.
- Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu
EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S,
Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann
HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial
Investigators. Transcatheter versus surgical aortic-valve replacement
in high-risk patients. N Engl J Med. 2011;364(23):2187-98.
- Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK,
Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ,
Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR,
Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses
JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA,
Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter
or surgical aortic-valve replacement in intermediate-risk patients. N
Engl J Med. 2016;374(17):1609-20.
- Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia
SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P,
Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY,
Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3
Investigators. Transcatheter aortic-valve replacement with a
balloon-expandable valve in low-risk patients. N Engl J Med.
2019;380(18):1695-1705.
- Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T,
Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti
SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar
J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason
TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low
Risk Trial Investigators. Transcatheter aortic-valve replacement with
a self-expanding valve in low-risk patients. N Engl J Med.
2019;380(18):1706-1715.
- Shivaraju A, Kodali S, Thilo C, Ott I, Schunkert H, von Scheidt W,
Leon MB, Kastrati A, Kasel AM. Overexpansion of the SAPIEN 3
Transcatheter Heart Valve: A Feasibility Study. JACC Cardiovasc
Interv. 2015;8(15):2041-2043
- Mathur M, McCabe JM, Aldea G, Pal J, Don CW. Overexpansion of the 29
mm SAPIEN 3 transcatheter heart valve in patients with large aortic
annuli (area> 683 mm2): A case series. Catheter
Cardiovasc Interv. 2018 ;91(6):1149-1156.
- Barr P, Ormiston J, Stewart J, Nand P, Ramanathan T, Webster M.
Transcatheter Aortic Valve Implantation In Patients With a Large
Aortic Annulus. Heart Lung Circ. 2018 ;27(3):e11-e14.
- Miyasaka M, Yoon SH, Sharma RP, Maeno Y, Jaideep S, Taguri M, Kato S,
Kawamori H, Nomura T, Ochiai T, Nemanpour S, Chakravarty T, Nakamura
M, Wen C, Makkar R. Clinical Outcomes of Transcatheter Aortic Valve
Implantation in Patients With Extremely Large Annulus and SAPIEN 3
Dimensions Based on Post-Procedural Computed Tomography. Circ J. 2019
;83(3):672-680.
- Buchanan KD, Rogers T, Shults C, Ben-Dor I, Satler LF, Waksman R.
Successful transcatheter aortic valve replacement in an oversized
800mm2 annulus and bicuspid aortic valve. Cardiovasc
Revasc Med. 2018;19(8S):65-67.
- Blanke P. Influence of computed tomography-based over-sizing on the
incidence of para-valvular regurgitation of a new generation
transcatheter valve: Early results of the Intermediate Risk S3 Cohort
PARTNER II trial. Presented at EuroPCR 2015. May 20, 2015, Paris,
France
- Sengupta A, Zaid S, Kamioka N, Terre J, Miyasaka M, Hirji SA, Hensey
M, Geloo N, Petrossian G, Robinson N, Sarin E, Ryan L, Yoon SH, Tan
CW, Khalique OK, Kodali SK, Kaneko T, Shah PB, Wong SC, Salemi A,
Sharma K, Kozina JA, Szerlip MA, Don CW, Gafoor S, Zhang M, Newhart Z,
Kapadia SR, Mick SL, Krishnaswamy A, Kini A, Ahmad H, Lansman SL, Mack
MJ, Webb JG, Babaliaros V, Thourani VH, Makkar RR, Leon MB, George I,
Tang GHL.. Mid-term outcomes of transcatheter aortic valve replacement
in extremely large annuli with edwards SAPIEN 3 valve. JACC Cardiovasc
Interv. 2020 13(2):210-216.